Matt Martin is a co-founder and the CEO of Saros Therapeutics. He is also a Venture Partner at Pathway Bioventures, a Seed stage fund investing in precision therapeutics. Matt has more than 15 years of management and leadership experiences with research based startups in roles at universities, startups, and early-stage investment groups. His startup operational experience includes both healthcare and bio-based renewable fuels. He was trained with a PhD in Physics from Carnegie Mellon University and an MBA from the University of Chicago Booth School of Business.